• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Oracle Supports Africa Clinical Research Network (ACRN) to Advance a New Era of Clinical Research, Launches First Trial

    5/5/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email

    African-led organization empowers clinicians and research professionals to accelerate equitable research and innovation with Oracle's leading safety solutions and powerful analytics

    AUSTIN, Texas, May 5, 2026 /PRNewswire/ -- The Africa Clinical Research Network (ACRN) has launched its first clinical trial with Oracle in Africa, which commenced in February 2026. The PROgnostic Testing to Enhance Clinical Triage of Pre-eclampsia in Africa (PROTECT-Africa) trial aims to define, validate, and evaluate the clinical performance of placental biomarkers using innovative point-of-care platforms. The study will predict the absence or occurrence of severe pre-eclampsia-related maternal and fetal outcomes among African women with hypertensive disorders of pregnancy.

    (PRNewsfoto/Oracle)

    This trial is being conducted in Zimbabwe, Rwanda, and Tanzania and aims to recruit 1,106 pregnant women. Pre-eclampsia, along with severe complications such as eclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, is a leading cause of maternal and fetal morbidity globally, particularly in resource-limited settings across Africa.

    ACRN selected Oracle's clinical trial and safety applications to advance its region-led, patient-centric research initiatives, focused on delivering essential treatments to communities faster and more equitably. The comprehensive Oracle cloud platform, including Oracle Clinical One, Argus Safety, and analytics, can help ACRN automate workflows, manage critical data, and run more efficient trials with the goal of enhancing safety and expanding patient access to clinical research across Africa.

    "Our mission at ACRN is to empower African researchers to lead and participate in clinical trials that directly address the health needs of our communities," said Tariro Makadzange, chief executive officer, Africa Clinical Research Network. "Oracle's robust and integrated clinical trial and safety solutions will enable us to conduct studies with greater efficiency, transparency, and, most importantly, an unwavering focus on patient well-being."

    Delivering new research and innovation across Africa

    Currently, less than three percent of global clinical trials are conducted in Africa1. To help change this dynamic and expand access to research opportunities, ACRN is building a pan-African clinical research ecosystem to address the significant disparity in research representation between Africa and the rest of the world. ACRN aims to accelerate medical innovations that are relevant and accessible to African populations by leveraging Oracle's modern, cloud-based clinical trial infrastructure and supporting local research teams. As part of this effort, ACRN has selected an initial cohort of 59 network sites across 14 countries: Senegal, The Gambia, Ghana, Nigeria, Kenya, Uganda, Ethiopia, Rwanda, Tanzania, Malawi, Botswana, South Africa, Zambia, and Zimbabwe.

    In addition to the PROTECT-Africa trial, ACRN plans to launch additional clinical trials focused on global health this year. With Oracle's leading clinical and safety solutions, the organization can optimize study startup, streamline trial execution, and improve data connectivity and quality, all while maintaining high levels of patient safety. ACRN's initiative to build robust, self-sustaining clinical research capacity across Africa can contribute to a more equitable and globally representative landscape of medical innovation.

    "Our collaboration with the Africa Clinical Research Network is a significant step toward advancing modern, patient-centric research that can help accelerate scientific breakthroughs across Africa," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "Together, we are creating the digital framework to enable innovation and AI integration into clinical research across the continent. The organization's on-the-ground expertise and dedication, combined with our cloud-based clinical trial and safety solutions, create a meaningful opportunity to drive innovation throughout the region, help bridge the research gap between Africa and the rest of the world, and ultimately support better health outcomes for communities."

    Learn more about the ACRN and Oracle collaboration in this video.

    Learn how customers like ACRN use Oracle's unified life sciences platform to manage the full clinical trial lifecycle—from planning and site activation to data collection, analysis, and safety reporting—at www.oracle.com/lifesciences.

    About Africa Clinical Research Network

    The Africa Clinical Research Network (ACRN) is an African-led organization building a high-quality, connected platform for the delivery of clinical trials across Africa. ACRN works with healthcare institutions, investigators, industry, and public sector partners to strengthen site readiness, workforce capability, regulatory coordination, and data-driven trial execution. Its mission is to expand access to research opportunities and accelerate the development of medicines and health innovations relevant to African populations. www.acrnhealth.com

    About Oracle Life Sciences

    Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the life sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.

    About Oracle

    Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

    Trademarks

    Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

    1 Ethiopian Journal of Health Science - Breaking the barriers for conducting clinical trials in Africa: A need for higher commitment and collaborations, May 2024, https://pmc.ncbi.nlm.nih.gov/articles/PMC12110202/

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-supports-africa-clinical-research-network-acrn-to-advance-a-new-era-of-clinical-research-launches-first-trial-302761684.html

    SOURCE Oracle

    Get the next $ORCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    6/11/2026$200.00 → $220.00Outperform
    BMO Capital Markets
    5/12/2026$210.00 → $235.00Outperform
    Oppenheimer
    5/7/2026$255.00Neutral → Buy
    Arete
    4/24/2026$225.00Outperform
    Wedbush
    4/10/2026Buy → Neutral
    Cleveland Research
    3/24/2026$200.00Buy
    BofA Securities
    3/11/2026$210.00Neutral → Overweight
    Analyst
    3/11/2026$205.00 → $200.00Outperform
    BMO Capital Markets
    More analyst ratings

    $ORCL
    SEC Filings

    View All

    SEC Form 144 filed by Oracle Corporation

    144 - ORACLE CORP (0001341439) (Subject)

    6/24/26 4:35:45 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Oracle Corporation

    424B5 - ORACLE CORP (0001341439) (Filer)

    6/23/26 8:52:53 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-K filed by Oracle Corporation

    10-K - ORACLE CORP (0001341439) (Filer)

    6/22/26 4:12:40 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $220.00 from $200.00 previously

    6/11/26 7:53:42 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oppenheimer reiterated coverage on Oracle with a new price target

    Oppenheimer reiterated coverage of Oracle with a rating of Outperform and set a new price target of $235.00 from $210.00 previously

    5/12/26 8:03:13 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by Arete with a new price target

    Arete upgraded Oracle from Neutral to Buy and set a new price target of $255.00

    5/7/26 7:59:26 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FiscalNote Appoints Key Compton as President and Chief Executive Officer

    Investor since 2020 and board member since 2021 tapped to lead company's return to growth FiscalNote Holdings, Inc. (OTC:NOTE), a global leader in AI-driven policy and regulatory intelligence, today announced that Key Compton has been appointed President and Chief Executive Officer. Compton, who has served as a FiscalNote board member since 2021 and as Audit Committee Chair, succeeds Josh Resnik, who in eight years of senior leadership built FiscalNote into a publicly traded, AI-driven policy intelligence leader, launched its flagship PolicyNote platform, and drove other key new initiatives such as the expansion of its API ecosystem. Resnik will support Compton’s transition into the role

    6/24/26 9:00:00 AM ET
    $NOTE
    $SPIR
    $LPSN
    Real Estate
    Telecommunications Equipment
    Consumer Discretionary
    Computer Software: Prepackaged Software

    Oracle Health Extends AI into the Operating Room in Collaboration with Theator

    AI-powered surgical intelligence solutions will improve documentation accuracy, patient care, and revenue cycle management for surgical proceduresAUSTIN, Texas, June 24, 2026 /PRNewswire/ -- Oracle Health and Theator are working together to provide AI-powered surgical intelligence solutions to Oracle Health customers in the U.S. With Theator's solutions, which capture surgical video footage and use AI to analyze it and cross-reference EHR data, surgical teams can benefit from automated reporting that is more clinically accurate, optimized for billing, and tailored to individual preferences, with no transcription or dictation required. Powered by Oracle Cloud Infrastructure (OCI), Theator's c

    6/24/26 8:05:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Baystate Health and Oracle Health Expand Strategic Collaboration to Create a Connected and Patient-Centered Care Experience

    Health system launches enterprise digital transformation to help caregivers focus more on patients, enhance care coordination, and make healthcare easier to navigate             AUSTIN, Texas, June 22, 2026 /PRNewswire/ -- Baystate Health, a not-for-profit, integrated health system in western Massachusetts, is expanding its strategic relationship with Oracle Health to create a more connected healthcare experience for patients and clinicians. Through this initiative, Baystate Health plans to accelerate the adoption of Oracle Health technologies across its network, including its health plan, Health New England. This modernization journey will be enabled by AI-powered solutions including Oracle

    6/22/26 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/14/25 4:41:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Rusckowski Stephen H

    4 - ORACLE CORP (0001341439) (Issuer)

    6/2/26 5:48:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W converted options into 2,114 shares, increasing direct ownership by 5% to 40,689 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    6/2/26 5:46:04 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Mihaljevic Tomislav

    4 - ORACLE CORP (0001341439) (Issuer)

    6/2/26 5:43:38 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    View All

    FiscalNote Appoints Key Compton as President and Chief Executive Officer

    Investor since 2020 and board member since 2021 tapped to lead company's return to growth FiscalNote Holdings, Inc. (OTC:NOTE), a global leader in AI-driven policy and regulatory intelligence, today announced that Key Compton has been appointed President and Chief Executive Officer. Compton, who has served as a FiscalNote board member since 2021 and as Audit Committee Chair, succeeds Josh Resnik, who in eight years of senior leadership built FiscalNote into a publicly traded, AI-driven policy intelligence leader, launched its flagship PolicyNote platform, and drove other key new initiatives such as the expansion of its API ecosystem. Resnik will support Compton’s transition into the role

    6/24/26 9:00:00 AM ET
    $NOTE
    $SPIR
    $LPSN
    Real Estate
    Telecommunications Equipment
    Consumer Discretionary
    Computer Software: Prepackaged Software

    Oracle Appoints Hilary Maxson as Chief Financial Officer

    AUSTIN, Texas, April 6, 2026 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced the appointment of Hilary Maxson as Chief Financial Officer (CFO). Maxson will report to Chief Executive Officer (CEO) Clay Magouyrk and lead the company's global finance organization, effective April 6, 2026. Maxson joins Oracle during a period of rapid growth as customer demand for cloud infrastructure exceeds supply. This growing demand for AI training and inferencing, multicloud database, and cloud applications has given Oracle the opportunity to build and scale its cloud infrastructu

    4/6/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Scales Up Nashville Offices to Support Rapid Growth

    New lease at the Neuhoff Development adds over 116,000 square feet to Oracle's Nashville footprintAUSTIN, Texas, March 26, 2026 /PRNewswire/ -- To accommodate future growth of its Nashville workforce, Oracle has signed a new 116,000 square foot lease within The Neuhoff District, at 1320 Adams Street. With this latest investment, Oracle will bring its office capacity in Nashville to about 2,000 seats across three locations, marking significant progress in the company's plans to create thousands of new tech jobs and become a cornerstone of the local economy. "New candidates as wel

    3/26/26 6:49:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Financials

    Live finance-specific insights

    View All

    Oracle Announces Record Q4 and FY 2026 Results Driven by Cloud Infrastructure & Cloud Applications

    Record Remaining Performance Obligations grew $85 billion in Q4 from $553 billion to $638 billionRecord Q4 Earnings per Share GAAP up 21% USD to $1.45, non-GAAP up 24% USD to $2.111Record Q4 Total Revenues $19.2 billion, up 21% USD, and up 20% constant currencyRecord Q4 Total Cloud Revenues $9.9 billion, up 47% USD, and up 46% constant currencyQ4 Cloud Infra (IaaS) Revenue $5.8 billion, up 93% USD, and up 92% constant currencyQ4 Cloud Apps (SaaS) Revenue $4.1 billion, up 10% USD, and up 9% constant currencyRecord FY 2026 Earnings per Share GAAP up 34% USD to $5.83, non-GAAP up 27% USD to $7.631Record FY 2026 Total Revenues $67.4 billion, up 17% USD, and up 16% constant currencyRecord FY 2026

    6/10/26 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Sets the Date for its Fourth Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on June 10, 2026, After the Close of the MarketAUSTIN, Texas, June 1, 2026 /PRNewswire/ -- Oracle Corporation today announced that its fourth quarter fiscal year 2026 results will be released on Wednesday, June 10th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About OracleOracle offers integrated suites of applications plus secure, autonomous inf

    6/1/26 4:01:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Announces Fiscal Year 2026 Third Quarter Financial Results

    Q3 Remaining Performance Obligations $553 billion, up 325% year-over-year in USDQ3 GAAP Earnings per Share up 24% to $1.27, Non-GAAP Earnings per Share up 21% to $1.79Q3 Total Revenue $17.2 billion, up 22% in USD and up 18% in constant currencyQ3 Cloud Revenue (IaaS plus SaaS) $8.9 billion, up 44% in USD and up 41% in constant currency Q3 Cloud Infrastructure Revenue (IaaS) $4.9 billion, up 84% in USD and up 81% in constant currencyQ3 Oracle Cloud Database (IaaS) Revenue up 35%, Multicloud Database Revenue up 531% in USDQ3 Cloud Application (SaaS) Revenue $4.0 billion, up 13% in USD and up 11% in constant currencyQ3 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 17% in USD and up 14% in co

    3/10/26 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/9/24 4:33:37 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/23 4:31:02 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/22 8:28:11 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology